| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $53.9M | +16.0% |
| Cost of Revenue | $10.8M | +2.1% |
| Gross Profit | $43.1M | +20.1% |
| R&D Expense | $3.2M | -20.7% |
| SG&A Expense | $25.0M | +21.4% |
| Operating Income | $14.9M | +32.5% |
| Pre-tax Income | $15.1M | +36.4% |
| Income Tax | $2.6M | +102.0% |
| Net Income | $12.5M |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.6M | +39.4% |
| Short-term Investments | $76.7M | -11.5% |
| Accounts Receivable | $13.8M | +40.0% |
| Current Assets | $146.8M | +5.4% |
| Total Assets | $188.4M | +4.7% |
| Current Liabilities | $7.7M | -33.2% |
| Total Liabilities | $10.1M | -28.6% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.9M | -6.8% |
| Capital Expenditures | $819K | -49.7% |
| Investing Cash Flow | $4.3M | +116.1% |
| Financing Cash Flow | -$7.6M | -62.7% |
| Free Cash Flow | $17.1M | -2.8% |
| +27.6% |
| EPS (Basic) | $0.62 | +26.5% |
| EPS (Diluted) | $0.60 | +27.7% |
| Stockholders' Equity |
| $178.2M |
| +7.5% |